1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 2:Patient AVM grades, embolization results, and adjuvant treatments
AVM S-M Grade No. Patients % Complete Obliteration Using Embolization (n) Clinical Complications (of Endovascular Procedures) Surgery Radiosurgery 1 3 67% (2) 1 Elective 2 5 60% (3) 2 3 9 67% (6) 3 Intracerebral hemorrhage, 1 subarachnoid hemorrhage 2 Urgent 0 4 14 29% (4) 2 Intracerebral hemorrhage, 1 extravasation of Onyx 6 5 12 8% (1) 2 Elective 1 Total 43
Note:—Twenty-nine out of 43 patients have concluded endovascular treatments; the remaining 14 patients are scheduled for further endovascular treatments.